dabigatran has been researched along with sotalol in 1 studies
Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
---|---|---|---|---|---|
3,887 | 261 | 3,490 | 2,196 | 346 | 291 |
Protein | Taxonomy | dabigatran (IC50) | sotalol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chung, CP; Daugherty, JR; Dickson, AL; Dupont, WD; Hung, AM; Murray, KT; Ray, WA; Smalley, W; Stein, CM; Zimmerman, E | 1 |
1 other study(ies) available for dabigatran and sotalol
Article | Year |
---|---|
Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Female; Flecainide; Hemorrhage; Hospitalization; Humans; Ischemic Stroke; Male; Medicare; Retrospective Studies; Rivaroxaban; Sotalol; Stroke; United States | 2023 |